Status:
UNKNOWN
Steroid-induced Diabetes Mellitus in Systemic Lupus Erythematosus (SLE) Patients
Lead Sponsor:
Assiut University
Conditions:
System; Lupus Erythematosus
Eligibility:
All Genders
18-75 years
Brief Summary
The aim of the study is to determine the prevalence of steroid-induced diabetes mellitus (SDM) among systemic lupus erythematosus (SLE) patients and identify and assess the associated risk factors .
Detailed Description
120 SLE patients who attend the SLE and Rheumatology Clinic will be recruited into the study. All patients need to fulfil at least four criteria from the American College of Rheumatology Classificatio...
Eligibility Criteria
Inclusion
- Inclusion criteria
- Both males and females
- Patients aged of 18-75 years.
- Clinically diagnosed as SLE patients.
- Receiving corticosteroid therapy.
- Prevalent cases of SDM with SLE.
- Exclusion criteria
- SLE patients who do not receive corticosteroid therapy.
- SLE patients with other types of diabetes mellitus.
Exclusion
Key Trial Info
Start Date :
September 1 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
April 20 2024
Estimated Enrollment :
120 Patients enrolled
Trial Details
Trial ID
NCT04024306
Start Date
September 1 2022
End Date
April 20 2024
Last Update
July 19 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Assiut university hospital
Asyut, Egypt, 71511